Avoiding Growth Factor During Paclitaxel Treatment in Breast Cancer
Clinical trial NCT02698891 · COMPLETED
Trial details
- NCT number
- NCT02698891
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-07
- Primary completion
- 2020-12-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.